Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Charlotte K.Y. Ng(Memorial Sloan Kettering Cancer Center), Jorge S. Reis‐Filho(Memorial Sloan Kettering Cancer Center)

Genome Biology

May 21, 2015

10.1186/s13059-015-0657-6

Cited by 135

Related Papers

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas

|Nature Communications|2018|138

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

|Oncotarget|2016|15